[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946
Sort by:

Proto Oncogene Mas (MAS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Proto Oncogene Mas (MAS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Proto Oncogene Mas (MAS1) Drugs in Development by Therapy Areas...

May 2022 38 pages

Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 41 pages

Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA,...

May 2022 180 pages

Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 192 pages

Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 61 pages

Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 180 pages

Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 53 pages

Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 38 pages

Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 51 pages

Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 35 pages

Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 39 pages

Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 35 pages

Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 3,500.00

Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications,...

May 2022 197 pages

Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 37 pages

Receptor Activity Modifying Protein 1 (Calcitonin Receptor Like Receptor Activity Modifying Protein 1 or RAMP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Receptor Activity Modifying Protein 1 (Calcitonin Receptor Like Receptor Activity Modifying Protein 1 or RAMP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type a...

May 2022 38 pages

Receptor Activity Modifying Protein 3 (Calcitonin Receptor Like Receptor Activity Modifying Protein 3 or RAMP3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Receptor Activity Modifying Protein 3 (Calcitonin Receptor Like Receptor Activity Modifying Protein 3 or RAMP3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type a...

May 2022 39 pages

Receptor Interacting Serine-Threonine Protein Kinase 1 (Cell Death Protein RIP or Receptor Interacting Protein 1 or Serine-Threonine Protein Kinase RIP or RIP1 or RIPK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Receptor Interacting Serine-Threonine Protein Kinase 1 (Cell Death Protein RIP or Receptor Interacting Protein 1 or Serine-Threonine Protein Kinase RIP or RIP1 or RIPK1 or EC 2.7.11.1) Drugs in Develo...

May 2022 51 pages

Recurrent Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Recurrent Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Recurrent Glioblastoma Multiforme (GBM) Drugs in Development by Stages,...

May 2022 168 pages

Recurrent Head And Neck Cancer Squamous Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Recurrent Head And Neck Cancer Squamous Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Recurrent Head And Neck Cancer Squamous Cell Carcinoma Dr...

May 2022 149 pages

Recurrent Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Recurrent Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Recurrent Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 42 pages

Refractory Angina Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Refractory Angina Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Refractory Angina Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 35 pages

Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development...

May 2022 148 pages

Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 37 pages

Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by...

May 2022 147 pages

Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Relapsing Multiple Sclerosis (RMS) Drugs in Development by Stages, Target, Mo...

May 2022 46 pages

Relapsing Remitting Multiple Sclerosis (RRMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Relapsing Remitting Multiple Sclerosis (RRMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Relapsing Remitting Multiple Sclerosis (RRMS) Drugs in Development...

May 2022 86 pages

Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Renal Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 250 pages

Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Resistant Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 44 pages

Respiratory Depression (Hypoventilation) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Respiratory Depression (Hypoventilation) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Respiratory Depression (Hypoventilation) Drugs in Development by Stages...

May 2022 37 pages

Respiratory Syncytial Virus Fusion Protein (RSV F Protein) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Respiratory Syncytial Virus Fusion Protein (RSV F Protein) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Respiratory Syncytial Virus Fu...

May 2022 84 pages

Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 132 pages

Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 91 pages

Retinoic Acid Receptor (RAR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Retinoic Acid Receptor (RAR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Retinoic Acid Receptor (RAR) Drugs in Development by Therapy...

May 2022 66 pages

Retinoid X Receptor (RXR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Retinoid X Receptor (RXR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Retinoid X Receptor (RXR) Drugs in Development by Therapy Areas...

May 2022 44 pages

Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 69 pages

Reverse Transcriptase (EC 2.7.7.49) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 3,500.00

Reverse Transcriptase (EC 2.7.7.49) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Reverse Transcriptase (EC 2.7.7.49) Drugs in Developm...

May 2022 132 pages

Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 38 pages

Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 59 pages

Rho Kinase (Rho Associated Coiled Coil Forming Protein Kinase or ROCK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Rho Kinase (Rho Associated Coiled Coil Forming Protein Kinase or ROCK or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Rho...

May 2022 64 pages

Rhodopsin (Opsin 2 or OPN2 or RHO) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Rhodopsin (Opsin 2 or OPN2 or RHO) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Rhodopsin (Opsin 2 or OPN2 or RHO) Drugs in Developmen...

May 2022 38 pages

Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Ribonucleoside Diphosphate Reductase (Ribonucleotide Reductase or RRM or EC 1.17.4.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Rib...

May 2022 60 pages

Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 35 pages

RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY RNA Directed RNA Polymerase (EC 2.7.7.48) Drugs...

May 2022 78 pages

Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Salivary Gland Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 76 pages

Salmonella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Salmonella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Salmonella Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 62 pages

Salmonella typhimurium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Salmonella typhimurium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Salmonella typhimurium Infections Drugs in Development by Stages, Target, MoA,...

May 2022 35 pages

Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sarcoidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 48 pages

Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1-2 Ca(2+) ATPase or SERCA2 or ATP2A2 or EC 7.2.2.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1-2 Ca...

May 2022 39 pages

Scar Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Scar Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Scar Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview o...

May 2022 49 pages

Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Schistosomiasis mansoni Infections Drugs in Development by Stages, Target, Mo...

May 2022 36 pages

Filters

Clear all

Search

Categories

209
1,199
32
238
214
187
155
140
64,297
1,312
1,311
2,468
184

Publishers

179
1
1,431
239
366
389
103
148
348
3
202
3
6
1,620
487
80
123
208
112
25
1,049
378
23
40
68
510
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,709
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
384
8
3
18
58
907
6
89
12
24
15
1,285
227
128
386
3
74
10
119
227
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
21
18
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
797
497
2
2
2
118
197
102
54
23
708
26
135
530
177
646
66,872

Price

—

Date

—

Pages

—

Offers

1
280
1
1